Although HYP alone only exhibits slight cytotoxicity towards HCC-SR cells (Supplementary Fig. S6I), it significantly enhances the sensitivity of HCC-SR cells to sorafenib in a dose-dependent manner (Fig. 6I, J, and Supplementary Fig. S6J, K). This evidence concerns the gene PHEX and hepatocellular carcinoma.